• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿皮质素 II 受体拮抗剂可减轻野百合碱诱导的大鼠心肌肥厚。

Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats.

机构信息

Department of Physiology, Diabetic Research Center, Chonbuk National University Medical School, Jeonju, Korea.

出版信息

Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1782-9. doi: 10.1152/ajpheart.00438.2010. Epub 2010 Sep 24.

DOI:10.1152/ajpheart.00438.2010
PMID:20870804
Abstract

Urotensin II (UII) is a vasoactive peptide with potent cardiovascular effects through a G protein-coupled receptor. Hypoxia stimulates the secretion of UII and atrial natriuretic peptide (ANP). However, the effect of UII on hypoxia-induced cardiac hypertrophy is still controversial. The present study was conducted to determine whether human UII (hUII)-mediated ANP secretion influences hypoxia-induced cardiac hypertrophy using in vitro and in vivo models. Hypoxia caused an increase in ANP secretion and a decrease in atrial contractility in isolated perfused beating rat atria. hUII (0.01 and 0.1 nM) attenuated hypoxia-induced ANP secretion without changing the atrial contractility, and the hUII effect was mediated by the UII receptor signaling involving phospholipase C, inositol 1,3,4 trisphosphate receptor, and protein kinase C. Rats treated with monocrotaline (MCT, 60 mg/kg) showed right ventricular hypertrophy with increases in pulmonary arterial pressure and its diameter and plasma levels of UII and ANP that were attenuated by the pretreatment with an UII receptor antagonist, urantide. An acute administration of hUII (5 μM injection plus 2.5 μM infusion for 15 min) decreased the plasma ANP level in MCT-treated rats but increased the plasma ANP level in MCT plus urantide-treated and sham-operated rats. These results suggest that hUII may deteriorate MCT-induced cardiac hypertrophy mainly through a vasoconstriction of the pulmonary artery and partly through the suppression of ANP secretion.

摘要

尾加压素 II(UII)是一种具有强大心血管作用的血管活性肽,通过 G 蛋白偶联受体发挥作用。缺氧可刺激 UII 和心钠肽(ANP)的分泌。然而,UII 对缺氧诱导的心肌肥厚的影响仍存在争议。本研究旨在使用体外和体内模型确定 UII 是否通过介导 ANP 分泌影响缺氧诱导的心肌肥厚。缺氧可引起分离的灌流跳动大鼠心房中 ANP 分泌增加和心房收缩力下降。UII(0.01 和 0.1 nM)可减轻缺氧诱导的 ANP 分泌,而不改变心房收缩力,UII 作用是通过 UII 受体信号转导介导的,涉及磷脂酶 C、三磷酸肌醇受体和蛋白激酶 C。给予单环毛蚓毒素(MCT,60mg/kg)的大鼠出现右心室肥厚,肺动脉压力及其直径增加,血浆 UII 和 ANP 水平升高,而 UII 受体拮抗剂 urantide 预处理可减轻这些变化。急性给予 UII(5μM 注射加 15min 2.5μM 输注)可降低 MCT 处理大鼠的血浆 ANP 水平,但可增加 MCT 加 urantide 处理和假手术处理大鼠的血浆 ANP 水平。这些结果表明,UII 可能主要通过肺动脉收缩和部分通过抑制 ANP 分泌使 MCT 诱导的心肌肥厚恶化。

相似文献

1
Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats.尿皮质素 II 受体拮抗剂可减轻野百合碱诱导的大鼠心肌肥厚。
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1782-9. doi: 10.1152/ajpheart.00438.2010. Epub 2010 Sep 24.
2
Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.乌瑞替德通过超声心动图改善野百合碱诱导的肺动脉高压大鼠模型右心室的结构和功能。
Clin Rheumatol. 2019 Jan;38(1):29-35. doi: 10.1007/s10067-018-3978-5. Epub 2018 Jan 23.
3
Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.血管紧张素-(1-7) 通过 Mas/PI3-kinase/Akt 轴和 Na+/H+ 交换刺激高心房起搏诱导的 ANP 分泌。
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1365-74. doi: 10.1152/ajpheart.00608.2009. Epub 2010 Feb 26.
4
Urotensin II stimulates high frequency-induced ANP secretion via PLC-PI 3K-PKC pathway.尾加压素 II 通过 PLC-PI3K-PKC 途径刺激高频诱导的 ANP 分泌。
Peptides. 2010 Jan;31(1):164-9. doi: 10.1016/j.peptides.2009.10.020. Epub 2009 Nov 5.
5
Attenuation of negatively regulated ANP secretion by calcium in hypertrophied atria.钙对肥厚心房中负调控的心房钠尿肽分泌的减弱作用。
Regul Pept. 2002 May 30;105(3):181-8. doi: 10.1016/s0167-0115(02)00014-9.
6
Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.内皮型一氧化氮合酶增强型G蛋白偶联受体拮抗剂通过依赖内皮素-1和不依赖内皮素-1的途径在野百合碱模型中抑制肺动脉高压。
Kaohsiung J Med Sci. 2014 Jun;30(6):267-78. doi: 10.1016/j.kjms.2014.02.014. Epub 2014 Apr 30.
7
Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.尾加压素II及尾加压素II相关肽(URP)与心脏缺血再灌注损伤
Peptides. 2008 May;29(5):770-7. doi: 10.1016/j.peptides.2007.08.013. Epub 2007 Aug 21.
8
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.血管紧张素AT2受体的选择性激活可减轻肺动脉高压的进展并抑制心肺纤维化。
Br J Pharmacol. 2015 May;172(9):2219-31. doi: 10.1111/bph.13044. Epub 2015 Feb 27.
9
Cardiac atrial natriuretic peptide in monocrotaline-induced pulmonary hypertensive rats.单氰胺诱导的肺动脉高压大鼠中的心钠素
Acta Paediatr Jpn. 1993 Aug;35(4):278-82. doi: 10.1111/j.1442-200x.1993.tb03053.x.
10
Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.乌瑞替肽可减轻野鼠诱发的肺动脉高血压。
Pulm Pharmacol Ther. 2011 Aug;24(4):386-93. doi: 10.1016/j.pupt.2011.03.003. Epub 2011 Mar 15.

引用本文的文献

1
Angiotensin-(1-9) ameliorates pulmonary arterial hypertension angiotensin type II receptor.血管紧张素-(1-9)改善肺动脉高压的血管紧张素II型受体。
Korean J Physiol Pharmacol. 2018 Jul;22(4):447-456. doi: 10.4196/kjpp.2018.22.4.447. Epub 2018 Jun 25.
2
Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.乌瑞替德通过超声心动图改善野百合碱诱导的肺动脉高压大鼠模型右心室的结构和功能。
Clin Rheumatol. 2019 Jan;38(1):29-35. doi: 10.1007/s10067-018-3978-5. Epub 2018 Jan 23.
3
The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats.
尾加压素 II 受体拮抗剂乌拉立肽可保护大鼠免受动脉粥样硬化的影响。
Exp Ther Med. 2013 Jun;5(6):1765-1769. doi: 10.3892/etm.2013.1052. Epub 2013 Apr 9.